Transactions

Supernus Pharmaceuticals, Inc.’s acquisition of Sage Therapeutics, Inc.

Date Announced:
06/16/2025

client:
Supernus Pharmaceuticals, Inc.

Status:
Pending

Value:
Up to $795 million